Pulmonary Vascular Diseases

This page lists the latest material on Pulmonary Vascular Diseases.

Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset Joseph Newman, Iryna Boubriak, David Jenkins, Choo Ng, Alessandro Ruggiero, Nicholas Screaton, John Cannon, Mark Toshner ERJ Open Res, 7 (4) 00431-2021; 10.1183/23120541.00431-2021
Improvement in exercise capacity after a modified Potts shunt in an adult patient with pulmonary arterial hypertension Petr Symersky, Samara M.A. Jansen, Suzanne K. Kamminga, Lilian J. Meijboom, Erik J. Lust, Pirooz Eghtesady, Robert M. Grady, Harm J. Bogaard ERJ Open Res, 7 (4) 00287-2021; 10.1183/23120541.00287-2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension Catherine E. Simpson, Megan Griffiths, Jun Yang, Melanie K. Nies, R. Dhananjay Vaidya, Stephanie Brandal, Lisa J. Martin, Michael W. Pauciulo, Katie A. Lutz, Anna W. Coleman, Eric D. Austin, D. Dunbar Ivy, William C. Nichols, Allen D. Everett, Paul M. Hassoun, Rachel L. Damico ERJ Open Res, 7 (4) 00378-2021; 10.1183/23120541.00378-2021
Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial Simon R. Schneider, Laura C. Mayer, Mona Lichtblau, Charlotte Berlier, Esther I. Schwarz, Stéphanie Saxer, Lu Tan, Michael Furian, Konrad E. Bloch, Silvia Ulrich ERJ Open Res, 7 (4) 00314-2021; 10.1183/23120541.00314-2021
Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study Chinthaka B. Samaranayake, Gregory Keir, Simon A.A. Slader, T. Tseng, Khoa Tran, James Anderson, Andrew McCann, Colm McCabe, John W. Upham ERJ Open Res, 7 (3) 00379-2021; 10.1183/23120541.00379-2021
Impairment of skeletal muscle oxygen extraction and cardiac output are matched in precapillary pulmonary hypertension Harrison Stubbs, Colin Church, Martin Johnson, Stephen Thomson ERJ Open Res, 7 (3) 00449-2021; 10.1183/23120541.00449-2021
Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study Suqiao Yang, Yuanhua Yang, Yixiao Zhang, Tuguang Kuang, Juanni Gong, Jifeng Li, Yidan Li, Jianfeng Wang, Xiaojuan Guo, Ran Miao ERJ Open Res, 7 (3) 00082-2021; 10.1183/23120541.00082-2021
A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension Gudula J.A.M. Boon, Wilbert B. van den Hout, Stefano Barco, Harm Jan Bogaard, Marion Delcroix, Menno V. Huisman, Stavros V. Konstantinides, Lilian J. Meijboom, Esther J. Nossent, Petr Symersky, Anton Vonk Noordegraaf, Frederikus A. Klok ERJ Open Res, 7 (3) 00719-2020; 10.1183/23120541.00719-2020
Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure Laurent Savale, Constance Vuillard, Jérémie Pichon, Athénaïs Boucly, Anne Roche, Mitja Jevnikar, Nathan Ebstein, Xavier Jaïs, Jérôme Le Pavec, David Montani, Olaf Mercier, Olivier Sitbon, Elie Fadel, Marc Humbert Eur Respir J, 58 (3) 2100466; 10.1183/13993003.00466-2021
Endothelial cells in the pathogenesis of pulmonary arterial hypertension Colin E. Evans, Nicholas D. Cober, Zhiyu Dai, Duncan J. Stewart, You-Yang Zhao Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020
The pathophysiological role of novel pulmonary arterial hypertension gene SOX17 Yukyee Wu, John Wharton, Rachel Walters, Eleni Vasilaki, Jurjan Aman, Lan Zhao, Martin R. Wilkins, Christopher J. Rhodes Eur Respir J, 58 (3) 2004172; 10.1183/13993003.04172-2020
Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease Michael F. Morris, Yash Pershad, Paul Kang, Lauren Ridenour, Ben Lavon, Maarten Lanclus, Rik Godon, Jan De Backer, Marilyn K. Glassberg Eur Respir J, 58 (3) 2004133; 10.1183/13993003.04133-2020
Oxygen therapy target ranges: finding the balance Christiaan Yu, Belinda R. Miller Eur Respir J, 58 (3) 2101023; 10.1183/13993003.01023-2021
Defining end-systolic pressure for single-beat estimation of right ventricle–pulmonary artery coupling: simple… but not really Inderjit Singh, Hannah Oakland, Ahmed Elassal, Paul M. Heerdt ERJ Open Res, 7 (3) 00219-2021; 10.1183/23120541.00219-2021
Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study Laurence Halimi, Carey M. Suehs, Gregory Marin, Clement Boissin, Anne-Sophie Gamez, Isabelle Vachier, Nicolas Molinari, Arnaud Bourdin ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020
Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry Stefan Guth, Andrea M. D'Armini, Marion Delcroix, Kazuhiko Nakayama, Elie Fadel, Stephen P. Hoole, David P. Jenkins, David G. Kiely, Nick H. Kim, Irene M. Lang, Michael M. Madani, Hiromi Matsubara, Aiko Ogawa, Jaquelina S. Ota-Arakaki, Rozenn Quarck, Roela Sadushi-Kolici, Gérald Simonneau, Christoph B. Wiedenroth, Bedrettin Yildizeli, Eckhard Mayer, Joanna Pepke-Zaba ERJ Open Res, 7 (3) 00850-2020; 10.1183/23120541.00850-2020
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment Clara Hjalmarsson, Barbro Kjellström, Kjell Jansson, Magnus Nisell, David Kylhammar, Mohammad Kavianipour, Göran Rådegran, Stefan Söderberg, Gerhard Wikström, Dirk M. Wuttge, Roger Hesselstrand ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment Mitja Jevnikar, Olivier Sanchez, Marc Humbert, Florence Parent Eur Respir J, 58 (2) 2101033; 10.1183/13993003.01033-2021
Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: is there a role for pre-test probability scores and home treatment? Angelo Porfidia, Enrico Pola, Roberto Pola Eur Respir J, 58 (2) 2100785; 10.1183/13993003.00785-2021
Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension Mathias Declercq, Lucas Treps, Siham Bousfia, Peter Carmeliet, Peter Witters Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021
Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype William M. Oldham, Edward Hess, Stephen W. Waldo, Marc Humbert, Gaurav Choudhary, Bradley A. Maron Eur Respir J, 58 (2) 2004625; 10.1183/13993003.04625-2020
Intrapulmonary bronchopulmonary anastomoses in COVID-19 respiratory failure Csaba Galambos, Douglas Bush, Steven H. Abman Eur Respir J, 58 (2) 2004397; 10.1183/13993003.04397-2020
Elevated pulmonary vascular resistance predicts mortality in COPD patients Katarina Zeder, Alexander Avian, Gerhard Bachmaier, Philipp Douschan, Vasile Foris, Teresa Sassmann, Natascha Troester, Luka Brcic, Michael Fuchsjaeger, Leigh Matthew Marsh, Bradley A. Maron, Horst Olschewski, Gabor Kovacs Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Karen M. Olsson, Marius M. Hoeper, Christine Pausch, Ekkehard Grünig, Doerte Huscher, David Pittrow, Stephan Rosenkranz, Henning Gall Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021
Serum and pulmonary uric acid in pulmonary arterial hypertension Laurent Savale, Satoshi Akagi, Ly Tu, Amélie Cumont, Raphaël Thuillet, Carole Phan, Benjamin Le Vely, Nihel Berrebeh, Alice Huertas, Xavier Jaïs, Vincent Cottin, Ari Chaouat, Cécile Tromeur, Athénaïs Boucly, Etienne Marie Jutant, Olaf Mercier, Elie Fadel, David Montani, Olivier Sitbon, Marc Humbert, Yuichi Tamura, Christophe Guignabert Eur Respir J, 58 (2) 2000332; 10.1183/13993003.00332-2020
Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow David G. Kiely, Robin Condliffe Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021
Lung blood and lymphatic vascular development Tsvetana Stoilova, Christiana Ruhrberg Eur Respir Monogr 2021; 91: 31-43
Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms Simon Malenfant, Marius Lebret, Émilie Breton-Gagnon, François Potus, Roxane Paulin, Sébastien Bonnet, Steeve Provencher Eur Respir Rev, 30 (160) 200284; 10.1183/16000617.0284-2020
Pulmonary haemodynamic response to exercise in highlanders versus lowlanders Silvia Ulrich, Stéphanie Saxer, Michael Furian, Patrick R. Bader, Paula Appenzeller, Philipp M. Scheiwiller, Maamed Mademilov, Ulan Sheraliev, Felix Tanner, Talantbek M. Sooronbaev, Konrad E. Bloch, Mona Lichtblau ERJ Open Res, 7 (2) 00937-2020; 10.1183/23120541.00937-2020
Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry Kris Bauchmuller, Robin Condliffe, Jennifer Southern, Catherine Billings, Athanasios Charalampopoulos, Charlie A. Elliot, Abdul Hameed, David G. Kiely, Ian Sabroe, A.A. Roger Thompson, Ajay Raithatha, Gary H. Mills ERJ Open Res, 7 (2) 00046-2021; 10.1183/23120541.00046-2021
Contrasting haemodynamic effects of exercise and saline infusion in older adults with pulmonary arterial hypertension Felipe H. Valle, Sam Esfandiari, Ho-Jun Jang, Felipe C. Fuchs, Stephen P. Wright, John Granton, Susanna Mak ERJ Open Res, 7 (1) 00183-2020; 10.1183/23120541.00183-2020
Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension Emilia M. Swietlik, Pavandeep Ghataorhe, Kasia I. Zalewska, John Wharton, Luke S. Howard, Dolores Taboada, John E. Cannon, Nicholas W. Morrell, Martin R. Wilkins, Mark Toshner, Joanna Pepke-Zaba, Christopher J. Rhodes Eur Respir J, 57 (4) 2003201; 10.1183/13993003.03201-2020
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension Stanislav Keranov, Oliver Dörr, Leili Jafari, Christian Troidl, Christoph Liebetrau, Steffen Kriechbaum, Till Keller, Sandra Voss, Timm Bauer, Jakob Lorenz, Manuel J. Richter, Khodr Tello, Henning Gall, Hossein A. Ghofrani, Eckhard Mayer, Christoph B. Wiedenroth, Stefan Guth, Holger Lörchner, Jochen Pöling, Prakash Chelladurai, Soni Savai Pullamsetti, Thomas Braun, Werner Seeger, Christian W. Hamm, Holger Nef Eur Respir J, 57 (4) 1901192; 10.1183/13993003.01192-2019
Targeted proteomics of right heart adaptation to pulmonary arterial hypertension Myriam Amsallem, Andrew J. Sweatt, Jennifer Arthur Ataam, Julien Guihaire, Florence Lecerf, Mélanie Lambert, Maria Rosa Ghigna, Md Khadem Ali, Yuqiang Mao, Elie Fadel, Marlene Rabinovitch, Vinicio de Jesus Perez, Edda Spiekerkoetter, Olaf Mercier, Francois Haddad, Roham T. Zamanian Eur Respir J, 57 (4) 2002428; 10.1183/13993003.02428-2020
The battle of new biomarkers for right heart failure in pulmonary hypertension: is the queen of hearts NT-proBNP defeated at last? Aida Llucià-Valldeperas, Jessie van Wezenbeek, Marie-José Goumans, Frances Sarah de Man Eur Respir J, 57 (4) 2004277; 10.1183/13993003.04277-2020
Utilising biomarkers to predict right heart maladaptive phenotype: a step toward precision medicine Soni Savai Pullamsetti, Khodr Tello, Werner Seeger Eur Respir J, 57 (4) 2004506; 10.1183/13993003.04506-2020
“The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment.” Silvia Ulrich and Ekkehard Grunig. Eur Respir J 2021; 57: 2004376 Eur Respir J, 57 (3) 2054376; 10.1183/13993003.54376-2020
PP218 – Direct effects of cigarette smoke in pulmonary arterial cells: Implications in arterial remodeling and vascular tone maintenance Javier Sevilla-Montero, Spain
ERS statement on chronic thromboembolic pulmonary hypertension M. Delcroix (Leuven, Belgium), G. Simonneau (Le Kremlin-Bicêtre, France), E. Mayer (Bad Nauheim, Germany) Thursday, 18 March 2021
Thrombolysis for massive pulmonary embolisms in morbid obesity: a multisite case–control study Chinthaka B. Samaranayake, Gregory Keir, Colm McCabe, James Anderson, Khoa Tran, John W. Upham ERJ Open Res, 7 (1) 00762-2020; 10.1183/23120541.00762-2020
Connecting the dots: the role of connexins in the pulmonary vascular response to hypoxia Martin Witzenrath, Wolfgang M. Kuebler Eur Respir J, 57 (3) 2004573; 10.1183/13993003.04573-2020
Targeting HIF2a-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension David Macias, Stephen Moore, Alexi Crosby, Mark Southwood, Xinlin Du, Huiling Tan, Shanhai Xie, Arlette Vassallo, Alexander J.T. Wood, Eli M. Wallace, Andrew S. Cowburn Eur Respir J, 57 (3) 1902061; 10.1183/13993003.02061-2019
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study Robert A. Lewis, Iain Armstrong, Carmel Bergbaum, Melanie J. Brewis, John Cannon, Athanasios Charalampopoulos, A. Colin Church, J. Gerry Coghlan, Rachel J. Davies, Konstantinos Dimopoulos, Charlie Elliot, J. Simon R. Gibbs, Wendy Gin-Sing, Gulam Haji, Abdul G. Hameed, Luke S. Howard, Martin K. Johnson, Aleksander Kempny, David G. Kiely, Francesco Lo Giudice, Colm McCabe, Andrew J. Peacock, Oyinkansola Peleyeju, Joanna Pepke-Zaba, Gary Polwarth, Laura Price, Ian Sabroe, Benjamin E. Schreiber, Karen Sheares, Dolores Taboada, A.A. Roger Thompson, Mark R. Toshner, Ivy Wanjiku, S. John Wort, Janelle Yorke, Robin Condliffe Eur Respir J, 57 (2) 2000124; 10.1183/13993003.00124-2020
The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment Silvia Ulrich, Ekkehard Grunig Eur Respir J, 57 (2) 2004376; 10.1183/13993003.04376-2020
Cardiovascular mortality and morbidity in pulmonary embolism Behnood Bikdeli, Carmen Rodríguez, Alberto García-Ortega, David Jiménez Eur Respir Monogr 2020; 88: 184-197
Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases Etienne-Marie Jutant, Maria-Rosa Ghigna, David Montani, Marc Humbert Eur Respir Monogr 2020; 88: 167-183
Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions Victor Margelidon-Cozzolino, Vincent Cottin, Sophie Dupuis-Girod, Julie Traclet, Kais Ahmad, Jean-François Mornex, Ségolène Turquier ERJ Open Res, 7 (1) 00078-2020; 10.1183/23120541.00078-2020
Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli Daniel J. Lachant, Christina Bach, Alexander Fe, R. James White, Neil A. Lachant ERJ Open Res, 7 (1) 00554-2020; 10.1183/23120541.00554-2020
Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy Mari Nishizaki, Aiko Ogawa, Hiromi Matsubara ERJ Open Res, 7 (1) 00725-2020; 10.1183/23120541.00725-2020
The clinical value of cardiopulmonary exercise testing in the modern era Pierantonio Laveneziana, Marcello Di Paolo, Paolo Palange Eur Respir Rev, 30 (159) 200187; 10.1183/16000617.0187-2020
Upfront triple combination therapy in severe paediatric pulmonary arterial hypertension Meindina G. Haarman, Marilyne Lévy, Marcus T.R. Roofthooft, Johannes M. Douwes, Theresia R. Vissia-Kazemier, Isabelle Szezepanski, Rolf M.F. Berger, Damien Bonnet Eur Respir J, 57 (1) 2001120; 10.1183/13993003.01120-2020
Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated Harm Jan Bogaard, Olivier Sitbon Eur Respir J, 57 (1) 2004258; 10.1183/13993003.04258-2020
Prevalence and outcomes of pulmonary hypertension after percutaneous closure of atrial septal defect: a systematic review and meta-analysis Selai Akseer, Eric Horlick, Varnita Vishwanath, Benjamin Hobbes, Ella Huszti, Susanna Mak, Douglas S. Lee, Lusine Abrahamyan Eur Respir Rev, 29 (158) 200099; 10.1183/16000617.0099-2020
Differential diagnosis and treatment approach to pulmonary artery sarcoma: a case report and literature review Eva Cervilla-Muñoz, Francisco Galeano-Valle, Jorge Del-Toro-Cervera, Enrique Calleja-Cartón, Pablo Demelo-Rodríguez ERJ Open Res, 6 (3) 00124-2020; 10.1183/23120541.00124-2020
Pulmonary arterial hypertension-associated changes in gut pathology and microbiota Ravindra K. Sharma, Aline C. Oliveira, Tao Yang, Seungbum Kim, Jasenka Zubcevic, Victor Aquino, Gilberto O. Lobaton, Ruby Goel, Elaine M. Richards, Mohan K. Raizada ERJ Open Res, 6 (3) 00253-2019; 10.1183/23120541.00253-2019
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey Catharina Belge, Rozenn Quarck, Laurent Godinas, David Montani, Pilar Escribano Subias, Jean-Luc Vachiéry, Heba Nashat, Joanna Pepke-Zaba, Marc Humbert, Marion Delcroix ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020
Importance of computed tomography in defining segmental disease in chronic thromboembolic pulmonary hypertension Micheal C. McInnis, David Wang, Laura Donahoe, John Granton, John Thenganatt, Kongteng Tan, John Kavanagh, Marc de Perrot ERJ Open Res, 6 (4) 00461-2020; 10.1183/23120541.00461-2020
Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Barbro Kjellström, Anna Sandqvist, Clara Hjalmarsson, Magnus Nisell, Per Näsman, Bodil Ivarsson ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020
Social deprivation in Scottish populations with pulmonary hypertension secondary to connective tissue disease and chronic thromboembolic disease Michael McGettrick, Paul McCaughey, Alexander MacLellan, Melanie Brewis, A. Colin Church, Martin K. Johnson ERJ Open Res, 6 (4) 00297-2019; 10.1183/23120541.00297-2019
Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH Steffen D. Kriechbaum, Lillith Scherwitz, Christoph B. Wiedenroth, Felix Rudolph, Jan-Sebastian Wolter, Moritz Haas, Ulrich Fischer-Rasokat, Andreas Rolf, Christian W. Hamm, Eckhard Mayer, Stefan Guth, Till Keller, Stavros V. Konstantinides, Mareike Lankeit, Christoph Liebetrau ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020
Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series Joe Zhang, Blair Merrick, Genex L. Correa, Luigi Camporota, Andrew Retter, Andrew Doyle, Guy W. Glover, Peter B. Sherren, Stephen J. Tricklebank, Sangita Agarwal, Boris E. Lams, Nicholas A. Barrett, Nicholas Ioannou, Jonathan Edgeworth, Christopher I.S. Meadows ERJ Open Res, 6 (4) 00463-2020; 10.1183/23120541.00463-2020
ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly Sheila Ramjug, Jason Weatherald, Sandeep Sahay, Johad Khoury, Vasile Foris, Nagaraj Chandran, Aleksandar Bokan, Laurent Godinas, Marion Delcroix ERJ Open Res, 6 (4) 00304-2020; 10.1183/23120541.00304-2020
“Chronic thromboembolic pulmonary hypertension in Saudi Arabia: preliminary results from the SAUDIPH registry”. Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Pekka Hämmäinen, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun and Nadeen Alharbi. ERJ Open Res 2019; 6: 00218-2019. ERJ Open Res, 6 (4) 00218-2019-AUT; 10.1183/23120541.50218-2019
Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society Martine Remy-Jardin, Christopher J. Ryerson, Mark L. Schiebler, Ann N.C. Leung, James M. Wild, Marius M. Hoeper, Philip O. Alderson, Lawrence R. Goodman, John Mayo, Linda B. Haramati, Yoshiharu Ohno, Patricia Thistlethwaite, Edwin J.R. van Beek, Shandra Lee Knight, David A. Lynch, Geoffrey D. Rubin, Marc Humbert Eur Respir J, 57 (1) 2004455; 10.1183/13993003.04455-2020
Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease? Eleni Sofianopoulou, Colin Church, Gerry Coghlan, Luke Howard, Martin Johnson, David G. Kiely, Allan Lawrie, James Lordan, Martin R. Wilkins, Stephen J. Wort, Nicholas W. Morrell, Mark R. Toshner Eur Respir J, 56 (2) 1902334; 10.1183/13993003.02334-2019
Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m Mona Lichtblau, Stéphanie Saxer, Michael Furian, Laura Mayer, Patrick R. Bader, Philipp M. Scheiwiller, Maamed Mademilov, Ulan Sheraliev, Felix C. Tanner, Talant M. Sooronbaev, Konrad E. Bloch, Silvia Ulrich Eur Respir J, 56 (2) 1902474; 10.1183/13993003.02474-2019
Risk stratification in pulmonary arterial hypertension using Bayesian analysis Manreet K. Kanwar, Mardi Gomberg-Maitland, Marius Hoeper, Christine Pausch, David Pittrow, Geoff Strange, James J. Anderson, Carol Zhao, Jacqueline V. Scott, Marek J. Druzdzel, Jidapa Kraisangka, Lisa Lohmueller, James Antaki, Raymond L. Benza Eur Respir J, 56 (2) 2000008; 10.1183/13993003.00008-2020
JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk Puja Mehta, Coziana Ciurtin, Marie Scully, Marcel Levi, Rachel C. Chambers Eur Respir J, 56 (3) 2001919; 10.1183/13993003.01919-2020
Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension Olivier Sitbon, Vincent Cottin, Matthieu Canuet, Pierre Clerson, Virginie Gressin, Loïc Perchenet, Laurent Bertoletti, Hélène Bouvaist, François Picard, Grégoire Prévot, Emmanuel Bergot, Gérald Simonneau Eur Respir J, 56 (3) 2000673; 10.1183/13993003.00673-2020
Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter? Athiththan Yogeswaran, Manuel Jonas Richter, Natascha Sommer, Hossein Ardeschir Ghofrani, Werner Seeger, Henning Gall, Khodr Tello Eur Respir J, 56 (3) 1901892; 10.1183/13993003.01892-2019
Iron bioavailability and cardiopulmonary function during ascent to very high altitude David A. Holdsworth, Matthew C. Frise, Josh Bakker-Dyos, Christopher Boos, Keith L. Dorrington, David Woods, Adrian Mellor, Peter A. Robbins Eur Respir J, 56 (3) 1902285; 10.1183/13993003.02285-2019
Mechanical circulatory support in refractory cardiogenic shock due to influenza virus-related myocarditis Jan-Thorben Sieweke, Muharrem Akin, Sebastian Stetskamp, Christian Riehle, Danny Jonigk, Ulrike Flierl, Tobias J. Pfeffer, Valentin Hirsch, Jochen Dutzmann, Marius M. Hoeper, Christian Kühn, Johann Bauersachs, Andreas Schäfer Eur Respir J, 56 (3) 2000925; 10.1183/13993003.00925-2020
A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension Stefano Ghio, Valentina Mercurio, Federico Fortuni, Paul R. Forfia, Henning Gall, Ardeschir Ghofrani, Stephen C. Mathai, Jeremy A. Mazurek, Monica Mukherjee, Manuel Richter, Laura Scelsi, Paul M. Hassoun, Khodr Tello Eur Respir J, 56 (3) 2000513; 10.1183/13993003.00513-2020
Imaging risk in pulmonary arterial hypertension Roberto Badagliacca, Carmine Dario Vizza Eur Respir J, 56 (3) 2002313; 10.1183/13993003.02313-2020
Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Mathew Suji Eapen, Wenying Lu, Archana Vijay Gaikwad, Prem Bhattarai, Collin Chia, Ashutosh Hardikar, Greg Haug, Sukhwinder Singh Sohal Eur Respir J, 56 (4) 2003167; 10.1183/13993003.03167-2020
The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension Mark W. Dodson, Kelli Sumner, Jadyn Carlsen, Meghan M. Cirulis, Emily L. Wilson, Abhishek Gadre, Timothy M. Fernandes, Lynette M. Brown, D. Hunter Best, C. Gregory Elliott Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020
In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography Salim Si-Mohamed, Nader Chebib, Monica Sigovan, Lea Zumbihl, Ségoléne Turquier, Sara Boccalini, Loic Boussel, Jean-Francois Mornex, Vincent Cottin, Philippe Douek Eur Respir J, 56 (4) 2002608; 10.1183/13993003.02608-2020
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors Jason Weatherald, Louise Bondeelle, Marie-Camille Chaumais, Christophe Guignabert, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Philippe Rousselot, Marc Humbert, Anne Bergeron, David Montani Eur Respir J, 56 (4) 2000279; 10.1183/13993003.00279-2020
CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension Michael Newnham, Katherine Bunclark, Nisha Abraham, Samantha Ali, Liliana Amaral-Almeida, John E. Cannon, Natalie Doughty, Choo Ng, Anie Ponnaberanam, Karen Sheares, Nicola Speed, Dolores Taboada, Mark Toshner, Steven Tsui, David P. Jenkins, Joanna Pepke-Zaba Eur Respir J, 56 (4) 1902096; 10.1183/13993003.02096-2019
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients Basile Mouhat, Matthieu Besutti, Kevin Bouiller, Franck Grillet, Charles Monnin, Fiona Ecarnot, Julien Behr, Gilles Capellier, Thibaud Soumagne, Sébastien Pili-Floury, Guillaume Besch, Guillaume Mourey, Quentin Lepiller, Catherine Chirouze, François Schiele, Romain Chopard, Nicolas Meneveau Eur Respir J, 56 (4) 2001811; 10.1183/13993003.01811-2020
How can we better predict pulmonary blood clots in patients hospitalised for COVID-19? Laurent Bertoletti, Menno V. Huisman Eur Respir J, 56 (4) 2003092; 10.1183/13993003.03092-2020
Mild parenchymal lung disease is still lung disease Robin Condliffe, David G. Kiely, Robert A. Lewis Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020
Mild parenchymal lung disease is still lung disease Laurent Godinas, Sergio Harari, Joan A. Barberà, David Montani Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020
Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi Behnood Bikdeli, David Jiménez, Alfonso Muriel, Deisy Barrios, Aitor Ballaz, Peter Verhamme, Manuel Monreal Eur Respir J, 56 (5) 2000538; 10.1183/13993003.00538-2020
Oral iron supplementation with ferric maltol in patients with pulmonary hypertension Karen M. Olsson, Jan Fuge, Torben Brod, Jan C. Kamp, Jan Schmitto, Tibor Kempf, Johann Bauersachs, Marius M. Hoeper Eur Respir J, 56 (5) 2000616; 10.1183/13993003.00616-2020
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension Yang-Yang He, Yi Yan, Xin Jiang, Jun-Han Zhao, Zhe Wang, Tao Wu, Yong Wang, Shan-Shan Guo, Jue Ye, Tian-Yu Lian, Xi-Qi Xu, Jin-Lan Zhang, Kai Sun, Fu-Hua Peng, Yu-Ping Zhou, Yi-Min Mao, Xue Zhang, Ji-Wang Chen, Shu-Yang Zhang, Zhi-Cheng Jing Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020
Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from China Jieying Wang, Mengtao Li, Qian Wang, Xiao Zhang, Junyan Qian, Jiuliang Zhao, Dong Xu, Zhuang Tian, Wei Wei, Xiaoxia Zuo, Miaojia Zhang, Ping Zhu, Shuang Ye, Wei Zhang, Yi Zheng, Wufang Qi, Yang Li, Zhuoli Zhang, Feng Ding, Jieruo Gu, Yi Liu, Yanhong Wang, Yan Zhao, Xiaofeng Zeng Eur Respir J, 56 (5) 1902157; 10.1183/13993003.02157-2019
The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg? Christopher J. Rhodes Eur Respir J, 56 (5) 2002350; 10.1183/13993003.02350-2020
Altered pulmonary capillary blood volume in childhood sickle cell disease Plamen Bokov, Priscilla Boizeau, Jade Pautrat, Florence Missud, Aissatou Ba, Zinédine Haouari, André Denjean, Christophe Delclaux, Malika Benkerrou Eur Respir J, 56 (6) 2000379; 10.1183/13993003.00379-2020
Incidence and significance of venous thromboembolism in critically ill pulmonary tuberculosis patients Angela Lau, Wendy Sligl, Ken Sun, James Barrie, Richard Long Eur Respir J, 56 (6) 2001753; 10.1183/13993003.01753-2020
Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: the BACS score Luis Jara-Palomares, David Jiménez, Behnood Bikdeli, Alfonso Muriel, Parth Rali, Yugo Yamashita, Takeshi Morimoto, Takeshi Kimura, Raphael Le Mao, Antoni Riera-Mestre, Ana Maestre, Fares Moustafa, Manuel Monreal Eur Respir J, 56 (6) 2002336; 10.1183/13993003.02336-2020
Exertional dyspnea in patients with OSA: pulmonary gas exchange and systemic vascular abnormalities A. Elbehairy (Alexandria, Egypt), N. Geneidy (Alexandria, Egypt), M. El Hoshy (Alexandria, Egypt), M. El Feky (Alexandria, Egypt), D. El-Sanhoury (Alexandria, Egypt), N. Abd Elwahab (Alexandria, Egypt)
The impact of Initial Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: a French prospective cohort. F. Couturaud (Brest, France), C. Orione (Brest, France), C. Tromeur (Brest, France), P. Le Floch (Brest, France), P. Salaun (Brest, France), C. Leroyer (Brest, France)
Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis A. Mulles (MANILA, Philippines), A. Nicolas (MANILA, Philippines), H. Chiu (MANILA, Philippines), R. Villalobos (MANILA, Philippines)
Retrospective application of the YEARS algorithm to an ambulatory PE clinic cohort S. Toor (Leicester, United Kingdom), H. Mcauley (Leicester, United Kingdom), R. Spriggs (Leicester, United Kingdom), E. Bailie (Leicester, United Kingdom), N. Parmar (Leicester, United Kingdom), N. Greening (Leicester, United Kingdom)
Changes in sleep-disordered breathing from the acute to the stable phase of pulmonary embolism and impact of right ventricular dysfunction: preliminary findings of ESAET study A. Garcia Ortega (Valencia, Spain), G. Oscullo (Valencia, Spain), E. Mañas-Baena (Madrid, Spain), A. Garcia-Sanchez (Madrid, Spain), R. Lopez-Reyes (Valencia, Spain), J. Jimenez-Aguilella (Valencia, Spain), P. Calvillo (Valencia, Spain), J. Gomez-Olivas (Valencia, Spain), S. Navarro-Rosales (Valencia, Spain), M. Selma-Ferrer (Valencia, Spain), E. Zaldivar-Olmeda (Valencia, Spain), C. Navarro-Soriano (Valencia, Spain), D. Jimenez-Castro (Madrid, Spain), M. Martinez-Garcia (Valencia, Spain)
Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders D. Velasco Álvarez (Madrid, Spain), B. Bikdeli (New York, United States of America), A. Muriel (Madrid, Spain), P. Marchena (Barcelona, Spain), I. Tzoran Rosenthal (Haifa, Israel), R. Malý (Hradec Kralove, Czech Republic), R. López Reyes (Valencia, Spain), A. Riera Mestre (Barcelona, Spain), M. Monreal (Barcelona, Spain), D. Jimenez Castro (Madrid, Spain)
Machine learning algorithm for the diagnosis of pulmonary embolism: a proof of concept study K. Exarchos (Ioannina, Greece), A. Aggelopoulou (Ioannina, Greece), K. Bartziokas (Ioannina, Greece), E. Tsina (Ioannina, Greece), C. Tagkas (Ioannina, Greece), V. Drouvis (Ioannina, Greece), O. Toli (Ioannina, Greece), K. Kostikas (Ioannina, Greece)